MVMiguel Angel Vilches-Ferron

Miguel Angel Vilches-Ferron

*This is an algorithmically generated author record based on publicly available information.

Miguel Angel Vilches-Ferron has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra M Lopes

    Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) , Porto

    1 shared publication
  • Ana Clavero

    Instituto de Investigación Biosanitaria ibs. GRANADA , Granada

    1 shared publication
  • Ana Cristina Abreu

    Department of Chemistry and Physics, Research Centre CIAIMBITAL, University of Almería, Ctra. Sacramento, s/n, 04120 Almería, Spain

    1 shared publication
  • Ana del Mar Salmerón

    Department of Chemistry and Physics, Research Centre CIAIMBITAL, University of Almería, Ctra. Sacramento, s/n, 04120 Almería, Spain

    1 shared publication
  • Andrea Espuch

    Hospital Universitario Torrecárdenas, Unidad de Reproducción Humana Asistida , Almería

    1 shared publication
  • Andrea Guzmán-Jiménez

    Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada , Granada

    1 shared publication

Latest Publications

  • Open Access

    Application of a single “Universal warming protocol” for vitrified donor oocytes: A multicenter study

    by Paloma Troncoso-Perez, Cristina Gonzalez-Navas, Maria Elisabetta Coccia, Rossella Fucci, Patrizia Falcone, Francesco Bertocci, Rita Picone, Daniel Fernando Sosa-Rosales, Nuria Lopez-Perez, Enrique Criado-Scholz, et al.

    Purpose The objective of the multicenter study is to demonstrate the efficacy of the “Universal Warming Protocol (UWP)” using different devitrification media in donor oocytes that were previously vitrified in a single egg bank. Method A total of 2172 oocytes (metaphase II) were vitrified at Ovobank (Spain) using Kitazato vitrification media (Kitazato, Japan). The oocytes were devitrified at three different centers. Group A: 1021 oocytes devitrified with Kitazato media (Kitazato, Japan); Group B: 496 oocytes devitrified with Irvine media (Fujifilm Irvine Scientific, USA); Group C: 655 oocytes devitrified with RapidWarm Omni media (Vitrolife, Sweden). The study parameters included survival rate, fertilization rate, cleavage rate, blastulation rate, and a pregnancy rate confirmed by a biochemical test; transferring embryos at D + 3 and D + 5; and clinical pregnancy rate, transferring embryos at D + 3 and D + 5. Results The survival rate was statistically higher in Group C (94%) compared to Group A (86%) and Group B (85%) (P value < 0.01). There were no statistically significant differences in the remaining parameters: fertilization rate (A: 77%, B: 74%, C: 73%); cleavage rate (A: 83%, B: 83%, C: 80%); blastulation rate (A: 52%, B: 58%, C: 57%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 3 (A: 38%, B: 33%, C: 33%); a pregnancy rate confirmed by a biochemical test in transferring embryos at D + 5 (A: 54%, B: 76%, C: 65%); clinical pregnancy rate in transferring embryos at D + 3 (A: 27%, B: 13%, C: 18%); clinical pregnancy rate in transferring embryos at D + 5 (A: 39%, B: 57%, C: 60%). Conclusions The idea that oocyte devitrification medium should always be from the same supplier is questionable. Therefore, it is feasible to use different devitrification media for donor oocytes that were vitrified with the same vitrification medium.


    • 29 January 2025
      • p. 105206

    Withdrawn : Application of a single "Universal warming protocol" for vitrified donor oocytes: A multicenter study.

    by Paloma Troncoso-Perez, Cristina Gonzalez-Navas, Maria Elisabetta Coccia, Rossella Fucci, Patrizia Falcone, Francesco Bertocci, Rita Picone, Daniel Fernando Sosa-Rosales, Nuria López-Perez, Enrique Criado-Scholz, et al.

    Author wanted to withdraw the paper as they are not interested in having it published in the journal Cryobiology. Approved by EIC and Publisher. As S5 was not published in SD, so we have proceeded with expiring the article from the production system

  • Open Access

    A comprehensive study of common and rare genetic variants in spermatogenesis-related loci identifies new risk factors for idiopathic severe spermatogenic failure

    by Andrea Guzmán-Jiménez, Sara González-Muñoz, Miriam Cerván-Martín, Nicolás Garrido, José A Castilla, M Carmen Gonzalvo, Ana Clavero, Marta Molina, Saturnino Luján, Samuel Santos-Ribeiro, et al.

    STUDY QUESTION: Can genome-wide genotyping data be analysed using a hypothesis-driven approach to enhance the understanding of the genetic basis of severe spermatogenic failure (SPGF) in male infertility? SUMMARY ANSWER: Our findings revealed a significant association between SPGF and the SHOC1 gene and identified three novel genes (PCSK4, AP3B1, and DLK1) along with 32 potentially pathogenic rare variants in 30 genes that contribute to this condition. WHAT IS KNOWN ALREADY: SPGF is a major cause of male infertility, often with an unknown aetiology. SPGF can be due to either multifactorial causes, including both common genetic variants in multiple genes and environmental factors, or highly damaging rare variants. Next-generation sequencing methods are useful for identifying rare mutations that explain monogenic forms of SPGF. Genome-wide association studies (GWASs) have become essential approaches for deciphering the intricate genetic landscape of complex diseases, offering a cost-effective and rapid means to genotype millions of genetic variants. Novel methods have demonstrated that GWAS datasets can be used to infer rare coding variants that are causal for male infertility phenotypes. However, this approach has not been previously applied to characterize the genetic component of a whole case–control cohort. STUDY DESIGN, SIZE, DURATION: We employed a hypothesis-driven approach focusing on all genetic variation identified, using a GWAS platform and subsequent genotype imputation, encompassing over 20 million polymorphisms and a total of 1571 SPGF patients and 2431 controls. Both common (minor allele frequency, MAF > 0.01) and rare (MAF < 0.01) variants were investigated within a total of 1797 loci with a reported role in spermatogenesis. This gene panel was meticulously assembled through comprehensive searches in the literature and various databases focused on male infertility genetics. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study involved a European cohort using previously and newly generated data. Our analysis consisted of three independent methods: (i) variant-wise association analyses using logistic regression models, (ii) gene-wise association analyses using combined multivariate and collapsing burden tests, and (iii) identification and characterisation of highly damaging rare coding variants showing homozygosity only in SPGF patients. MAIN RESULTS AND THE ROLE OF CHANCE: The variant-wise analyses revealed an association between SPGF and SHOC1-rs12347237 (P = 4.15E−06, odds ratio = 2.66), which was likely explained by an altered binding affinity of key transcription factors in regulatory regions and the disruptive effect of coding variants within the gene. Three additional genes (PCSK4, AP3B1, and DLK1) were identified as novel relevant players in human male infertility using the gene-wise burden test approach (P < 5.56E−04). Furthermore, we linked a total of 32 potentially pathogenic and recessive coding variants of the selected genes to 35 different cases. LARGE SCALE DATA: Publicly available via GWAS catalog (accession number: GCST90239721). LIMITATIONS, REASONS FOR CAUTION: The analysis of low-frequency variants presents challenges in achieving sufficient statistical power to detect genetic associations. Consequently, independent studies with larger sample sizes are essential to replicate our results. Additionally, the specific roles of the identified variants in the pathogenic mechanisms of SPGF should be assessed through functional experiments. WIDER IMPLICATIONS OF THE FINDINGS: Our findings highlight the benefit of using GWAS genotyping to screen for both common and rare variants potentially implicated in idiopathic cases of SPGF, whether due to complex or monogenic causes. The discovery of novel genetic risk factors for SPGF and the elucidation of the underlying genetic causes provide new perspectives for personalized medicine and reproductive counselling. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Spanish Ministry of Science and Innovation through the Spanish National Plan for Scientific and Technical Research and Innovation (PID2020-120157RB-I00) and the Andalusian Government through the research projects of ‘Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020)’ (ref. PY20_00212) and ‘Proyectos de Investigación aplicada FEDER-UGR 2023’ (ref. C-CTS-273-UGR23). S.G.-M. was funded by the previously mentioned projects (ref. PY20_00212 and PID2020-120157RB-I00). A.G.-J. was funded by MCIN/AEI/10.13039/501100011033 and FSE ‘El FSE invierte en tu futuro’ (grant ref. FPU20/02926). IPATIMUP integrates the i3S Research Unit, which is partially supported by the Portuguese Foundation for Science and Technology (FCT), financed by the European Social Funds (COMPETE-FEDER) and National Funds (projects PEstC/SAU/LA0003/2013 and POCI-01-0145-FEDER-007274). S.S. is supported by FCT funds (10.54499/DL57/2016/CP1363/CT0019), ToxOmics-Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, and is also partially supported by the Portuguese Foundation for Science and Technology (UIDP/00009/2020 and UIDB/00009/2020). S. Larriba received support from Instituto de Salud Carlos III (grant: DTS18/00101), co-funded by FEDER funds/European Regional Development Fund (ERDF)—a way to build Europe) and from ‘Generalitat de Catalunya’ (grant 2021SGR052). S. Larriba is also sponsored by the ‘Researchers Consolidation Program’ from the SNS-Dpt. Salut Generalitat de Catalunya (Exp. CES09/020). All authors declare no conflict of interest related to this study.


  • Solution NMR in human embryo culture media as an option for assessment of embryo implantation potential

    by Ana M. Salmerón, Ana Cristina Abreu, Miguel Vilches‐Ferrón, Ignacio Fernández

    NMR offers the potential to holistically screen hundreds of metabolites and has already proved to be a powerful technique able to provide a global picture of metabolic changes in a wide range of biological systems underlying complex and multifactorial matrixes. This review covers the literature until May 2020 centered on the early prediction of the viability of in vitro developed embryos using several analytical techniques, including NMR. Nowadays, the predominant non‐invasive technique for selecting viable embryos is based on morphology, where variables associated with the rate of cleavage and blastocyst formation are evaluated by the embryologist following standardized criteria that are somewhat subjective. This morphological approach is therefore inadequate for the prediction of embryo quality, and several studies have focused on developing new non‐invasive methods using molecular approaches based particularly on metabolomics. This review outlines the potential of NMR as one of these non‐invasive in vitro methods based on the analysis of spent embryo culture media.